Company intelligence / Profile preview

Lithoz

Ownership: Private
Employees: ~70
Development stage: Commercial

Overview

Lithoz’s ceramic additive manufacturing platforms are commercially available and widely adopted in the medical device sector. Clinical studies on their LithaBone material for bioceramic implants have shown over a 92% total success rate in relevant applications such as jaw and dental implants. The company has achieved ISO13485 certification for its quality management system supporting medical device production.

Therapeutic areas: Other
Modalities: DeviceMaterialSoftware
Industry: Chemicals & Materials

Partnerships

Wendth IndiaZENIT Smart PolycrystalsHimed

Beyond the preview

Go deeper on Lithoz.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Lithoz.

Explore the full profile